BoTULS: a multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A.
about
Spotlight on botulinum toxin and its potential in the treatment of stroke-related spasticityConversion Ratio between Botox®, Dysport®, and Xeomin® in Clinical PracticeSystematic literature review of abobotulinumtoxinA in clinical trials for adult upper limb spasticityBotulinum Toxin Type A for the Treatment of Neuropathic Pain in Neuro-RehabilitationIncidence, Time Course and Predictors of Impairments Relating to Caring for the Profoundly Affected arm After Stroke: A Systematic Review.A Meta-Analysis Evaluating the Effectiveness of Two Different Upper Limb Hemiparesis Interventions on Improving Health-Related Quality of Life Following StrokeValid and reliable instruments for arm-hand assessment at ICF activity level in persons with hemiplegia: a systematic review.Effects of Assist-As-Needed Upper Extremity Robotic Therapy after Incomplete Spinal Cord Injury: A Parallel-Group Controlled Trial.Robot Assisted Training for the Upper Limb after Stroke (RATULS): study protocol for a randomised controlled trialBibliometrics of NIHR HTA monographs and their related journal articles.Budget impact analysis of botulinum toxin A therapy for upper limb spasticity in the United Kingdom.Factors influencing goal attainment in patients with post-stroke upper limb spasticity following treatment with botulinum toxin A in real-life clinical practice: sub-analyses from the Upper Limb International Spasticity (ULIS)-II StudyEvaluation of the cost per patient per injection of botulinum toxin A in upper limb spasticity: comparison of two preparations in 19 countries.Home-based reach-to-grasp training for people after stroke: study protocol for a feasibility randomized controlled trial.Elbow spasticity during passive stretch-reflex: clinical evaluation using a wearable sensor system.Conceptualisation and development of the arm activity measure (ArmA) for assessment of activity in the hemiparetic arm.Haptic-based neurorehabilitation in poststroke patients: a feasibility prospective multicentre trial for robotics hand rehabilitationRepetitive arm functional tasks after stroke (RAFTAS): a pilot randomised controlled trial.The Canadian occupational performance measure for patients with stroke: a systematic review.Poststroke chronic disease management: towards improved identification and interventions for poststroke spasticity-related complications.Poststroke hypertonicity: upper limb assessment and treatment.Assessing the neurophysiological effects of botulinum toxin treatment for adults with focal limb spasticity: a systematic review.Chemodenervation for treatment of limb spasticity following spinal cord injury: a systematic review.Therapeutic use of botulinum toxin in neurorehabilitation.Results from the Upper Limb International Spasticity Study-II (ULISII):a large, international, prospective cohort study investigating practice and goal attainment following treatment with botulinum toxin A in real-life clinical management.Content of conventional therapy for the severely affected arm during subacute rehabilitation after stroke: An analysis of physiotherapy and occupational therapy practice.Rehabilitation plus OnabotulinumtoxinA Improves Motor Function over OnabotulinumtoxinA Alone in Post-Stroke Upper Limb Spasticity: A Single-Blind, Randomized Trial.Botulinum toxin type A combined with neurodynamic mobilization for upper limb spasticity after stroke: a case report.Is two better than one? Muscle vibration plus robotic rehabilitation to improve upper limb spasticity and function: A pilot randomized controlled trial.Combining Upper Limb Robotic Rehabilitation with Other Therapeutic Approaches after Stroke: Current Status, Rationale, and Challenges.Successive motor nerve blocks to identify the muscles causing a spasticity pattern: example of the arm flexion pattern.Intrathecal baclofen therapy versus conventional medical management for severe poststroke spasticity: results from a multicentre, randomised, controlled, open-label trial (SISTERS).Differences in utility elicitation methods in cardiovascular disease: a systematic review.Cost effectiveness of the occupation-based approach for subacute stroke patients: result of a randomized controlled trial.Adhesive taping vs. daily manual muscle stretching and splinting after botulinum toxin type A injection for wrist and fingers spastic overactivity in stroke patients: a randomized controlled trial.Arm Activity measure (ArmA) application for recording functional gain following focal spasticity treatmentSupplementary prescribing for spasticity managementEffect of botulinum toxin injection on length and force of the rectus femoris and triceps surae muscles during locomotion in patients with chronic hemiparesis (FOLOTOX)
P2860
Q26750450-6C34B89B-81FE-4DE3-9CDE-2FCA4A9E7C2EQ26766728-42F171C8-34FA-4C53-8294-5B6BE901B723Q26830501-B0A1926E-E961-44F3-8586-F2AA30C8D8B5Q28088625-E1F03E8F-D8A9-412D-9CE1-D7143AE191ADQ30252149-FB298939-064A-46D4-A8B2-87B96F73C943Q30476764-2BB3C21F-757B-468A-8226-4B70B5CB6578Q30514066-1723B796-E105-4D34-806E-AA9084C2486AQ33792745-A0A0F97F-B583-4FF6-A921-D469E4748EF3Q33921961-0219C00E-DBA7-4D91-B01B-7F4E57C5CE93Q35107556-7BC067F3-6AB9-40F9-839F-B3AC433186C7Q35284574-BC8B1636-A5E1-47A4-BC3D-F0AF9FA36769Q35564045-2E161FB8-D48B-4596-803F-369F165A1B28Q36429877-855216D5-8AB7-4CDF-B050-201094898460Q36909598-36D27A63-0CA5-44BC-B327-0626608463B4Q36952387-C7C4D493-530C-4B5F-8003-5CE68667AFFCQ37089107-AA6C4F10-82FF-4AB4-8F12-820CDA25AD24Q37351628-F80C099B-1267-43D0-B5C2-E084EA75C219Q37498667-D84BF4A3-197E-424F-88A6-5D77046105D4Q37714793-CA410175-A3E9-4D08-B04B-BCC9CE686E79Q37825979-39446F14-7F19-4620-AA25-97F182206607Q37885037-BDFE6EA5-CE8F-4079-8566-95ABA3B40E36Q37939194-638CFFCA-85A5-4B5F-A985-7827F38841A9Q38316027-EF20947F-0C4D-4A47-828F-85F421C9EBE4Q38414925-F0BB31AF-2930-4E9D-AE8B-414DD02B87F0Q38449494-6F9E2422-2AD3-4DF1-97B5-263B1D2C9071Q39018521-AD146897-F993-4722-B2C3-A1DF3AAE16EEQ41175112-9A3DDF36-06B1-4E43-8C04-F89AF42A0774Q42324130-3C2BDF4D-B41B-4EFC-AC95-D3CBE828BAE1Q42369669-F13608A0-7859-489C-A38B-088FCDCC17EAQ43375014-FD42FC4C-3287-4BB9-929E-18C3A6339644Q47391688-A2AF29B3-68CF-437F-A924-67F5CD40A8BFQ50077559-A6549CB7-6282-474B-9B6F-9132DBC4C12AQ50129904-09BB11A2-0CF6-41F9-8CF0-F54F8BE3AF99Q50892695-D414DC17-3956-4E98-A8FE-4D3791C620FFQ53528429-84971BF5-B129-4C30-9EE5-685DEDE42084Q57466784-FE1893E9-9B52-40AD-A817-34F79EAA8B49Q58468275-71369788-727B-42A1-B063-CA45FBD5F699Q58803153-865C55B4-124E-4177-BF14-21E1ADAEAD90
P2860
BoTULS: a multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
BoTULS: a multicentre randomis ...... e with botulinum toxin type A.
@en
BoTULS: a multicentre randomis ...... e with botulinum toxin type A.
@nl
type
label
BoTULS: a multicentre randomis ...... e with botulinum toxin type A.
@en
BoTULS: a multicentre randomis ...... e with botulinum toxin type A.
@nl
prefLabel
BoTULS: a multicentre randomis ...... e with botulinum toxin type A.
@en
BoTULS: a multicentre randomis ...... e with botulinum toxin type A.
@nl
P2093
P356
P1476
BoTULS: a multicentre randomis ...... e with botulinum toxin type A.
@en
P2093
BoTULS investigators
F van Wijck
P Shackley
P304
1-113, iii-iv
P356
10.3310/HTA14260
P577
2010-05-01T00:00:00Z